Immunabs Inc
ImmunAbs has assembled a team of experts with decades of experience in antibody-based therapeutics to find optimal treatments for patients with autoimmune diseases. In April 2024, ImmunAbs successfully completed a Phase 1 clinical trial in the United States and is preparing for a Phase 2 clinical trial. We have reached an important milestone in our journey to become a global leader in biopharmaceuticals. Our overarching vision is summarized in a simple but powerful motto:'Hope for patients, dreams for all'.” Contact : Sabrina Pan(below linekdin profile)
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
11
11 to 50 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 7 verified contacts at Immunabs Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Immunabs Inc
7 distinct titles indexed · top 7 shown.
- 1admin
- 1business development manager
- 1chief executive officer
- 1cmc pm
- 1director
- 1manager
- 1연구개발이사
Sign up to unlock all 7 contacts at Immunabs Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Immunabs Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.